Sign in to view content

A Novel Modifier Gene Therapy for Retinitis Pigmentosa: 2-Year Results of a Phase 1/2, Multicenter, Dose-Escalation Study of Subretinal OCU400

Syed Shah, MD

Video
Published 2025

Related

Episode 207: January 2020 Retinal Physician Preview: EHR Integration, Swept-Source OCTA, Intraoperative OCT, Optogenetics
Jayanth Sridhar, MD
Member Podcasts
2020
Ixoberogene Soroparvovec (Ixo-vec) IVT Gene Therapy for Neovascular AMD: Phase 2 LUNA Study Update
Glenn C. Yiu, MD, PhD
Updates from the Field
2025
Suprachoroidal Delivery of RGX-314 Gene Therapy for Diabetic Retinopathy: Phase II ALTITUDE Study
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2022

Category: Hereditary Retinal Disease & Genetics

See more